
J Neuropsychiatry Clin Neurosci 19:326-330, August 2007
doi: 10.1176/appi.neuropsych.19.3.326
© 2007 American Neuropsychiatric Association
The Effect of Divalproex Sodium on HIV Replication In Vivo
Julie D. Maggi, M.D., M.Sc., F.R.C.P.(C.) and
Mark H. Halman, M.D., F.R.C.P.(C.)
Received April 4, 2006; revised September 3, 2006; accepted September 26, 2006. Drs. Maggi and Halman are affiliated with St. Michaels Hospital, Mental Health Service, and the Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. Dr. Halman is also affiliated with St. Michaels Hospital, Centre for Research in Inner City Health, and St. Michaels Hospital, The Keenan Research Centre in the Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada. Address correspondence to Dr. Maggi, Room 17-033, Cardinal Carter Wing, St. Michaels Hospital, 30 Bond Street, Toronto, ON M5B 1W8; maggij{at}smh.toronto.on.ca
In vitro data suggest valproate activates HIV replication. This study prospectively assesses whether divalproex sodium causes an increase in HIV replication in patients. Eight participants had their HIV viral load measured over approximately 1 month. The largest increases in viral load occurred in patients without antiretroviral medication. No patients had an increase in Log10 HIV viral load 0.5. Further study is needed to understand implications.
Get information about faster international access.
a>
Privacy Policy
Copyright © 2007
American Neuropsychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|